Cargando…
17AAG Treatment Accelerates Doxorubicin Induced Cellular Senescence: Hsp90 Interferes with Enforced Senescence of Tumor Cells
Hsp90 chaperone has been identified as an attractive pharmacological target to combat cancer. However, some metastatic tumors either fail to respond to Hsp90 inhibition or show recovery necessitating irreversible therapeutic strategies. In response to this enforced senescence has been proposed as an...
Autores principales: | Sarangi, Upasana, Paithankar, Khande Rao, Kumar, Jonnala Ujwal, Subramaniam, Vaidyanathan, Sreedhar, Amere Subbarao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422084/ https://www.ncbi.nlm.nih.gov/pubmed/22915839 http://dx.doi.org/10.4137/DTI.S9943 |
Ejemplares similares
-
Repercussion of Mitochondria Deformity Induced by Anti-Hsp90 Drug 17AAG in Human Tumor Cells
por: Vishal, Chaturvedi, et al.
Publicado: (2011) -
The matrix metalloproteinase 7 (MMP7) links Hsp90 chaperone with acquired drug resistance and tumor metastasis
por: Kumar, Pankaj, et al.
Publicado: (2020) -
Hsp60 Chaperonin Acts as Barrier to Pharmacologically Induced Oxidative Stress Mediated Apoptosis in Tumor Cells with Differential Stress Response
por: Sarangi, Upasana, et al.
Publicado: (2013) -
Analysis and functional relevance of the chaperone TRAP-1 interactome in the metabolic regulation and mitochondrial integrity of cancer cells
por: Dharaskar, Shrikant Purushottam, et al.
Publicado: (2023) -
How the cell cycle enforces senescence
por: Cascales, Helena Silva, et al.
Publicado: (2017)